Alpha Mark Advisors, LLC Gsk PLC Transaction History

Alpha Mark Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$30.0 - $37.92 $840 - $1,061	28 Added 38.89%	100 $4,000
Q3 2022 Nov 14, 2022	SELL	$16.13 - $44.61 $290 - $802	-18 Reduced 20.0%	72 $2,000
Q3 2021 Nov 05, 2021	SELL	$38.79 - $43.16 $387 - $431	-10 Reduced 10.0%	90 $3,000
Q2 2020 Aug 10, 2020	BUY	$37.87 - $43.58 $2,650 - $3,050	70 Added 233.33%	100 $4,000
Q1 2020 Apr 24, 2020	BUY	$32.47 - $48.83 $974 - $1,464	30 New	30 $1,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Alpha Mark Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Mark Advisors, LLC with notifications on news.